Metro (B4B) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
1 Feb, 2026Executive summary
Q3 sales grew 4% portfolio-adjusted in local currency, in line with guidance, with all channels growing, especially FSD.
Adjusted EBITDA for Q3 was €327 million, roughly flat year-over-year, including a final negative effect from China license fee expiration.
Free cash flow was €239 million, mainly due to improved net working capital, though down from €384 million in Q3 22/23.
Net debt stands at €3.3 billion, slightly up year-over-year but down sequentially.
Management board was strengthened and leadership structure reorganized for greater operational focus.
Financial highlights
Q3 sales reached around €8 billion, with 4% growth at constant currency and inflation-adjusted growth of 2%.
Adjusted EBITDA declined by €9 million year-over-year, mainly due to post-transaction effects.
Earnings per share in Q3 were €0.04, with nine-month EPS at -€0.13, in line with guidance.
Gross margin in Q3 increased, though EBITDA margin declined from 4.3% to 4.1% due to higher sales.
Free cash flow was positive at €239 million, but lower than the prior year due to a strong comparison base.
Outlook and guidance
Full-year 2023/24 guidance confirmed: sales growth of 3–7%, adjusted EBITDA between -€100 million and +€50 million.
Segment Germany expected to grow below guidance range; West within range; East, Russia, and Others above range.
2030 targets reaffirmed: sales >€40bn, EBITDA >€2bn, free cash flow >€0.6bn, with 5–10% CAGR in sales and 5–7% CAGR in EBITDA.
EPS expected around breakeven for the year; dividend payout unlikely if EPS is zero or negative.
Slightly negative free cash flow and increase in net debt expected due to investments and lease portfolio extension.
Latest events from Metro
- Sales and EBITDA rose, with delivery driving growth and positive outlook for FY 2025/26.B4B
Q1 202611 Feb 2026 - Sales up 6%, but profitability declined; 2024/25 guidance and 2030 targets reaffirmed.B4B
Q4 202411 Jan 2026 - 6% revenue growth and higher EBITDA, with delivery as key driver; outlook remains positive.B4B
Q4 20254 Dec 2025 - Sales growth across all segments, but transformation costs weighed on earnings.B4B
Q3 202529 Jul 2025 - Sales growth offset by cost inflation and delisting agreement with EPGC.B4B
Q2 20255 Jun 2025 - Sales up 7.1% in local currency, but net income and free cash flow declined year-over-year.B4B
Q1 20255 Jun 2025